Cephalexin
Product Images NDC 67296-0320

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 67296-0320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Db58498b Ab09 4707 9bf4 2db878ace430 01)

FDA Label Image

Image (Db58498b Ab09 4707 9bf4 2db878ace430 02)

Image (Db58498b Ab09 4707 9bf4 2db878ace430 02)
This text is a description of Cephalexin capsules. Each capsule contains 250 mg of anhydrous cephalexin. It is a prescription medication indicated for the treatment of various infections. The usual adult dose is one capsule every 6 hours, with a maximum dose of 4 grams per day for severe infections. The manufacturer is Lupin Pharmaceuticals, based in the United States and India. Storage instructions advise keeping the capsules in a tight, light-resistant container at 20-25°C.*
FDA Label Image

Image (Db58498b Ab09 4707 9bf4 2db878ace430 03)

Image (Db58498b Ab09 4707 9bf4 2db878ace430 03)
This text provides dosage information for Cephalexin capsules. The usual adult dose is 250 mg every 6 hours, with the possibility of increasing the dose for severe infections up to a maximum of 4 g per day. Storage instructions recommend storing the capsules in a light-resistant container at 20° to 25°C. For further details, refer to the accompanying literature.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.